DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20181416

Role of cytohormonal study in normal pregnancy and in threatened abortion

Shailesh B. Patil, Milind B. Patil

Abstract


Background: It is certain from clinical experience of many that one or more hemorrhages in early pregnancy can still end up in good fetal outcome. So, our study deals with comparison of cytohormonal study in pregnancy and threatened abortion. The study was conducted with the aim of utilizing colpocytogram as a tool in assessing and treating cases of threatened abortion and comparing them with normal pregnant women.

Methods: Patients attending antenatal care unit on outdoor basis and labelled as normal pregnancy cases were considered as control group. The patients of threatened abortion were studied when they were admitted in Gynecology department for indoor treatment. Patients were studied taking into consideration their age, parity, number of abortions, complaints (P/V bleeding, pain in abdomen), gestational age, per abdomen and per vaginal findings and also USG findings and vaginal smear pattern.

Results: Maximum number of patients was present in the age group of 21-25 years in both the groups. While only 13.33% had normal smear pattern in threatened abortion group. 86.67% patients in threatened abortion group showed abnormal smear pattern. There is statistically significant difference was found (p<0.05). There is statistically significant was found (P<0.01) and indicates good effects of the drug on the vaginal epithelium.

Conclusions: The cytohormonal study acts as a simple, reliable, good, noninvasive method for evaluation of hormonal pattern in normal pregnancy and threatened abortion.

 


Keywords


Cytohormonal, Hormonal pattern, Normal pregnancy, Threatened abortion

Full Text:

PDF

References


Siriwachirachai T, Piriyasupong T. Effect of Dydrogesterone on Treatment of Threatened Miscarriage: A Systematic Review and Meta-Analyses. Thai J Obstet Gynaecol. 2011;19(3):97-104.

Pandian RU. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas. 2009;65(1):S47-50.

Palagiano A, Bulletti C, Pace MC, DE Ziegler D, Cicinelli E, Izzo A. Effects of vaginal progesteroneon pain and uterine contractility in patients with threatened abortion before twelve weeks of pregnancy. Ann NY Acad Sci. 2004;1034(1):200-10.

Sotiriadis A, Papatheodorou S, Makrydimas G. Threatened miscarriage: evaluation and management. BMJ. 2004;329(7458):152-5.

Tien JC, Tan TY. Non-surgical interventions for threatened and recurrent miscarriages. Singapore Med J. 2007;48(12):1074-90.

Duan L, Yan D, Zeng W, Yang X, Wei Q. Effect of progesterone treatment due to threatened abortion in early pregnancy for obstetric and perinatal outcomes. Early Hum Dev. 2010;86(1):41-3.

Sipilä P, Hartikainen Sorri Al, Oja H, Wendt L. Perinatal outcome of pregnancies complicated by vaginal bleeding. BJOG: Int J Obstet Gynaecol. 1992;99(12):959-63.

Datta D.C. Text book of Obstetrics, Including Perinatology and Contraception, 3rd Ed, New central book agency. 1992:172.

Arthur P. Camileri and N. Gauci: Progesterone Depot in Threatened Abortion, Am J Obstet Gyenecol. 1971;38(1):893-5.

Funatsu M, Hirato K, Kawamura E, Chiba H, Moriyama S, Yanaihara T. et al., Study on prognosis of threatened abortion assessed by multivariate analysis. Nippon Sanka Fujinka Gakkai Zasshi. 1990;42(7):689-96.

Novak Woodruff Gynaecologic and Obstetric pathology with clinical and endocrine relation: 5th ed, Springer;1963:594-611.

Salones H. A vaginal smear study in cases of Threatened Abortion. BJOG: Int J Obstet Gynaecol,1965;72(3):416-20.

Swyer GI, Little V. Progestational agents and disturbances of pregnancy. BJOG: Int J Obstet Gynaecol. 1965;72(6):104-21.

Pratibha P, Lalitha KR, Vaginal cytology in Threatened Abortion. J Obstet Gynaecol India. 1982;32:(6):369-71.

MacRae DJ. Vaginal cytology and the use of progestational agents. BJOG: An International J Obstet Gynaecol. 1965;72(6):1038-9.

Rock JA, Wentz AC, Cole KA, Kimball AW, Zacur HA. Fetal malformations following progesterone therapy during pregnancy: A preliminary report. Fertil Steril. 1985;44(1):117-9.

Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers T. A meta-analysis of randomized control trials of progestational agents in pregnancy. British J Obstet Gynaecol. 1989;96(3):265-74.

Reijnders FJ, Thomas CM, Doesburg WH, Rolland R, Eskes TK: Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: A double-blind clinical treatment. Br J Obstet Gynaecol. 1988;95(5):462-8.

Resseguie LJ, Hick JF, Bruen JA, Noller KL, O’Fallon WM, Kurland LT. Congenital malformations among offspring exposed in utero to progestins. Fertil Steril. 1985;43(4):514-9.